Showing results (191-200 of 216) with videos related to
Sort By:
Pageof 22
Frontiers in Pharmacology|March 22, 2021
What Matters Most to Lung Cancer Patients? A Qualitative Study in Italy and Belgium to Investigate Patient PreferencesSerena Petrocchi, Rosanne Janssens, Serena Oliveri, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 17, 2025
Synergizing Needs Assessments and Patient Preference Studies for Enhanced Patient-centred Decision-Making in HealthcareElise Schoefs, Alice Vanneste, Alessandra Blonda, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 13, 2019
Understanding Patients' Preferences: A Systematic Review of Psychological Instruments Used in Patients' Preference and Decision StudiesSelena Russo, Chiara Jongerius, Flavia Faccio, et al.Frontiers in Medicine|June 2, 2020
Risks in Antibiotic Substitution Following Medicine Shortage: A Health-Care Failure Mode and Effect Analysis of Six European HospitalsNenad Miljković, Brian Godman, Eline van Overbeeke, et al.The Journal of Biological Chemistry|May 30, 2002
kappa-Hefutoxin1, a novel toxin from the scorpion Heterometrus fulvipes with unique structure and function. Importance of the functional diad in potassium channel selectivityKellathur N Srinivasan, Vaithiyalingam Sivaraja, Isabelle Huys, et al.The Patient|March 4, 2021
Patient Preferences in Rare Diseases: A Qualitative Study in Neuromuscular Disorders to Inform a Quantitative Preference StudyA Cecilia Jimenez-Moreno, Eline van Overbeeke, Cathy Anne Pinto, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 2, 2021
A comprehensive review on non-clinical methods to study transfer of medication into breast milk - A contribution from the ConcePTION projectNina Nauwelaerts, Neel Deferm, Anne Smits, et al.Frontiers in Pharmacology|September 4, 2023
How can patient preferences be used and communicated in the regulatory evaluation of medicinal products? Findings and recommendations from IMI PREFER and call to actionRosanne Janssens, Liese Barbier, Mireille Muller, et al.Frontiers in Public Health|February 26, 2021
Patient Preferences for Lung Cancer Treatment: A Qualitative Study Protocol Among Advanced Lung Cancer PatientsIlaria Durosini, Rosanne Janssens, Reinhard Arnou, et al.Frontiers in Pharmacology|October 3, 2022
How to balance valuable innovation with affordable access to medicines in Belgium?Steven Simoens, Khadidja Abdallah, Liese Barbier, et al.Pageof 22